Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00586976 · ClinicalTrials.gov registry record · Phase 2
A Phase II/III Study of Continuous Local Anesthetic Infusion in Median Sternotomy Following Cardiac Surgery
A Phase 2 study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- Phase 2
- Development phase
- 125
- Enrollment target
NCT00586976: Clinical Trial Phase 2 study, sponsored by Mayo Clinic.
NCT00586976 is a Phase 2 study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 125 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00586976, a Phase 2 study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 125 participants
- Enrollment target
Study Summary
Cardiac surgery is associated with pain in the post-operative period. We plan to conduct a study of local anesthetic, ropivacaine, infusion into the sternal wound in adult patients undergoing cardiac surgery to see if it will be safe and result in improved pain control and reduced time to extubation, duration of ICU and hospital stay.
Interventions
- DRUG Normal saline
- DRUG Ropivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2005-07 |
| Est. Completion | 2008-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00586976
The ClinicalTrials.gov registry entry for NCT00586976 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Normal saline is the first listed.
NCT00586976 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00586976 about?
NCT00586976 is a clinical study titled "A Phase II/III Study of Continuous Local Anesthetic Infusion in Median Sternotomy Following Cardiac Surgery". Cardiac surgery is associated with pain in the post-operative period. We plan to conduct a study of local anesthetic, ropivacaine, infusion into the sternal wound in adult patients undergoing cardiac surgery to see if it will be safe and result in improved pain control and reduced time to extubation...
What is the current status of trial NCT00586976?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 125 participants. The study started on 2005-07. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00586976?
The interventions under investigation include: Normal saline (DRUG), Ropivacaine (DRUG).
Who is sponsoring clinical trial NCT00586976?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.